Literature DB >> 22141325

Menopausal symptoms and risk factors for cardiovascular disease in postmenopause.

A Cagnacci1, M Cannoletta, F Palma, R Zanin, A Xholli, A Volpe.   

Abstract

OBJECTIVES: Conflicting evidence indicates an increased risk for cardiovascular disease in postmenopausal women suffering from hot flushes. In this study, we tested whether, beyond hot flushes, menopausal symptoms are associated with biochemical and biophysical risk factors for cardiovascular disease.
METHODS: Retrospective cross-sectional analysis on 951 women in surgical or physiological postmenopause, recruited at the menopause outpatient service of our university hospital between April 2002 and December 2009. The Greene Climacteric Scale and its subscales for anxiety, depression, somatic symptoms, vasomotor symptoms and sexuality were used to evaluate menopausal complaints. Blood pressure, fasting glucose and lipids levels were evaluated as risk factors for cardiovascular disease. Anthropometric parameters and those derived by remote and reproductive medical history were used as possible confounders. All data were anonymously retrieved from an electronic database.
RESULTS: By multiple regression analysis, high density lipoprotein (HDL) cholesterol was inversely related to body mass index, the Greene Climacteric Scale score and years since menopause (R = 0.390; p = 0.0001). The total cholesterol/HDL cholesterol ratio was positively related to waist circumference and the Greene Climacteric Scale score (R = 0.356; p = 0.0001). Triglycerides (R = 0.353; p = 0.0001) and triglyceride/HDL cholesterol (R = 0.425; p = 0.0001) were positively related to waist circumference, the Greene Climacteric Scale score and the Greene vasomotor subscore. Glucose was positively related to waist circumference, years since menopause and the Greene Climacteric Scale score (R = 0.390; p = 0.0001). Blood pressure was not related to menopausal symptoms. The 10-year risk for cardiovascular disease calculated by the Framingham formula was related independently and directly to body mass index and the Greene Climacteric Scale score (R = 0.183; p = 0.0001).
CONCLUSIONS: Menopausal symptoms evaluated by a validated climacteric scale are associated with a worsening of biochemical risk factors for atherosclerosis and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22141325     DOI: 10.3109/13697137.2011.617852

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  14 in total

1.  Effects of soy phytoestrogens on pituitary-ovarian function in middle-aged female rats.

Authors:  Ivana M Medigović; Jasmina B Živanović; Vladimir Z Ajdžanović; Aleksandra L Nikolić-Kokić; Sanja D Stanković; Svetlana L Trifunović; Verica Lj Milošević; Nataša M Nestorović
Journal:  Endocrine       Date:  2015-07-28       Impact factor: 3.633

2.  Anxiety, depressive symptoms, and cardiac autonomic function in perimenopausal and postmenopausal women with hot flashes: a brief report.

Authors:  Polly Fu; Carolyn J Gibson; Wendy Berry Mendes; Michael Schembri; Alison J Huang
Journal:  Menopause       Date:  2018-12       Impact factor: 2.953

Review 3.  Vasomotor symptoms: natural history, physiology, and links with cardiovascular health.

Authors:  R C Thurston
Journal:  Climacteric       Date:  2018-02-02       Impact factor: 3.005

4.  Association of Premenstrual Syndrome with Blood Pressure in Young Adult Women.

Authors:  Elizabeth R Bertone-Johnson; Serena C Houghton; Brian W Whitcomb; Lynnette L Sievert; Sofija E Zagarins; Alayne G Ronnenberg
Journal:  J Womens Health (Larchmt)       Date:  2016-07-15       Impact factor: 2.681

5.  Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life.

Authors:  Kerry L Hildreth; Cemal Ozemek; Wendy M Kohrt; Patrick J Blatchford; Kerrie L Moreau
Journal:  Menopause       Date:  2018-09       Impact factor: 2.953

6.  Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies.

Authors:  Dongshan Zhu; Hsin-Fang Chung; Annette J Dobson; Nirmala Pandeya; Debra J Anderson; Diana Kuh; Rebecca Hardy; Eric J Brunner; Nancy E Avis; Ellen B Gold; Samar R El Khoudary; Sybil L Crawford; Gita D Mishra
Journal:  Am J Obstet Gynecol       Date:  2020-06-23       Impact factor: 8.661

7.  Symptom clusters predict risk of metabolic-syndrome and diabetes in midlife: the Study of Women's Health Across the Nation.

Authors:  Alexis N Reeves; Michael R Elliott; Maria M Brooks; Carrie A Karvonen-Gutierrez; Irina Bondarenko; Michelle M Hood; Siobán D Harlow
Journal:  Ann Epidemiol       Date:  2021-02-22       Impact factor: 6.996

8.  Alterations in adhesion molecules, pro-inflammatory cytokines and cell-derived microparticles contribute to intima-media thickness and symptoms in postmenopausal women.

Authors:  Nicté Figueroa-Vega; Carmen Moreno-Frías; Juan Manuel Malacara
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

9.  Lipid profiles and ischemic stroke risk: variations by sex within racial/ethnic groups.

Authors:  Tefera Gezmu; Dona Schneider; Kitaw Demissie; Yong Lin; Christine Giordano; Martin S Gizzi
Journal:  Int J Womens Health       Date:  2014-05-30

10.  Hypertensive disorders of pregnancy and menopausal symptoms: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality.

Authors:  Stephanie S Faubion; Amanda King; Andrea G Kattah; Carol L Kuhle; Richa Sood; Juliana M Kling; Kristin C Mara; Ekta Kapoor
Journal:  Menopause       Date:  2020-08-17       Impact factor: 3.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.